Fulminant hepatitis in an asymptomatic chronic carrier of hepatitis B virus mutant after withdrawal of low-dose methotrexate therapy for rheumatoid arthritis.
Hagiyama
H
H
Kubota
T
T
Komano
Y
Y
Kurosaki
M
M
Watanabe
M
M
Miyasaka
N
N
D000368:Aged; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology; D002353:Carrier State / Q000821:virology; D004279:DNA, Viral / Q000032:analysis; D004305:Dose-Response Relationship, Drug; D005260:Female; D014644:Genetic Variation; D006509:Hepatitis B / Q000209:etiology* / Q000473:pathology; D006515:Hepatitis B virus / Q000235:genetics; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008727:Methotrexate / Q000009:adverse effects*; D009154:Mutation
D004279:DNA, Viral; D007166:Immunosuppressive Agents; D008727:Methotrexate